BXI.TO Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-0.2881|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-60.96M|
|Gross Profit Margin (Quarterly)||-246.0%|
|Profit Margin (Quarterly)||-76687%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM)||Upgrade|
BXI.TO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Bioexx Specialty Proteins is down 87.50% over the last year vs and S&P 500 Total Return up 22.59%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for BXI.TO
Portfolio Strategies Featuring BXI.TO
Did Bioexx Specialty Proteins make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: Canada
- Headquarters State/Province: Ontario
- Incorporation Country: Canada
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: June 30, 2014
- Est. Current Fiscal Year End: December 31, 2014
- Last Fiscal Quarter End: N/A
- Last Fiscal Year End: N/A
Bioexx Specialty Proteins, Inc. is involved in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials.